Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,078,061
+$928,770 QoQ
Shares Held
3,400
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,866
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hilltop Holdings Inc. holds $34,832,079 across 13 Drug Manufacturers - General names. LLY ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
27,734 | $6,978,983 | |
| 2 | JNJ |
Johnson & Johnson
|
26,901 | $6,832,046 | |
| 3 | MRK |
Merck & Co., Inc.
|
38,494 | $4,946,478 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
3,400 | $4,078,061 | |
| 5 | PFE |
Pfizer Inc
|
120,367 | $2,898,436 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,819 | $2,756,612 | |
| 7 | AMGN |
Amgen Inc
|
5,905 | $2,138,318 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
23,318 | $1,343,582 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,078,061 | 3,400 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,149,291 | 3,424 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $9,852,667 | 9,168 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,574,240 | 16,480 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,490,366 | 8,326 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,233,319 | 8,758 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,216,916 | 8,053 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,492,168 | 7,328 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,038,454 | 3,356 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,408,242 | 4,381 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,426,695 | 4,163 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $2,320,938 | 4,321 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,896,554 | 4,044 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,260,007 | 3,669 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,410,312 | 3,855 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,012,084 | 3,130 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,152,637 | 3,555 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $927,552 | 3,239 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $984,447 | 3,564 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $895,780 | 3,877 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $803,778 | 3,502 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $623,418 | 3,337 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $483,051 | 2,861 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $223,805 | 1,512 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $207,358 | 1,263 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||